APOs Associated With Respiratory Viral Infections Before and During Early Pregnancy

Starting soon

Conditions studied: Respiratory Viral Infections, Adverse Pregnancy Outcomes

In brief

Adverse pregnancy outcomes (APOs) are a collection of conditions that have short-term and long-term effects of complications related to pregnancy and childbirth on pregnant women and their fetuses, including hypertensive disorders of pregnancy, gestational diabetes, preterm birth, large for gestational age, among others. Nearly 30% of all women experience an adverse pregnancy outcome during their reproductive years. Although, respiratory viral infections with epidemic and pandemic potential pose an omnipresent threat to public health, research focusing specifically on the maternal-infant population remains relatively scarce. Studies conducted in USA found that among pregnant women infected with influenza, the proportion of those with gestational hypertension or diabetes was higher than in pregnant women without influenza infection (13.9% vs. 11.1%). Research on the impact of respiratory viral infections on perinatal outcomes in China is limited, and we aim to establish of a large-scale, retroprospective maternal-child cohorts. This cohort study will systematically collect longitudinal data (e.g., detailed clinical history, timing of infection/vaccination, complication of pregnancy, and APOs) to assess the risk of respiratory viral infections to APOs, as well as facilitate multidisciplinary research.

Key facts

Study ID

NCT07257952

Run by

Shanghai General Hospital, China

People needed

1440

Starts

2026-07-05

Expected to finish

2028-11-30

Last updated by the study team

2026-04-23

Who can join

Age: 20 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female;
• Age 20 to 45 years old;
• Physician-diagnosed acute respiratory viral infection occurring within 6 months before pregnancy and/or at <24 weeks of gestation.

You may not qualify if…

• Pregestational T1D or T2D;
• Long-term use of immunosuppressants or glucocorticoids;
• Diseases that severely affect immune or metabolic function (e.g., HIV, SLE, rheumatoid arthritis);
• Severe mental illness or cognitive impairment;
• Women whose electronic medical records lack GDM screening and delivery records.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.